We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Max Planck Institute and Cellomics Announce Collaboration for High Content Screening Development

News   Nov 02, 2005

 
Max Planck Institute and Cellomics Announce Collaboration for High Content Screening Development
 
 
 

RELATED ARTICLES

Eye-rectile Dysfunction: Irreversible damage to color vision linked to popular drug

News

Study serves as a warning about excessive use or over-dosage of popular erectile dysfunction treatment

READ MORE

Nanoparticle-Encased Drug Shows Promise as Triple-Negative Breast Cancer Therapy

News

A new study from the George Washington University (GW) Cancer Center found that nanoparticle-encapsulated doxorubicin is promising in the treatment of triple-negative breast cancer.

READ MORE

On-demand, Adaptable and Automated Biopharmaceutical Manufacturing

News

Having the ability to produce small batches of drugs makes precision medicine a reality, and accelerates drug development.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE